| Ident. | Authors (with country if any) | Title |
|---|
| 000012 (2020) |
Thomas A. Hilimire [États-Unis] ; Aitor Nogales [États-Unis] ; Kevin Chiem [États-Unis] ; Javier Ortego [Espagne] ; Luis Martinez-Sobrido [États-Unis] | Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine. |
| 000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
| 000474 (2016) |
Jessica M. Cottreau [États-Unis] ; Viktorija O. Barr [États-Unis] | A Review of Antiviral and Antifungal Use and Safety during Pregnancy |
| 000482 (2015-11-30) |
Odile Launay [France] ; Vered Abitbol [France] ; Anne Krivine ; Lilia Ben Slama [France] ; Arnaud Bourreille [France] ; Jean Louis Dupas [France] ; Xavier Hébuterne [France] ; Guillaume Savoye [France] ; Dominique Deplanque [France] ; Yoram Bouhnik [France] ; Anne Laure Pelletier [France] ; Florence Galtier [France] ; David Laharie [France] ; Maria Nachury ; Frank Zerbib [France] ; Mathieu Allez [France] ; Gilles Bommelaer [France] ; Bernard Duclos [France] ; Frederic Lucht [France] ; Marie-Lise Gougeon [France] ; Eric Tartour [France] ; Flore Rozenberg [France] ; Thomas Hanslik [France] ; Laurent Beaugerie [France] ; Fabrice Carrat [France] | Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. |
| 000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
| 000A74 (2012) |
Nazan Tuna [Turquie] ; Oguz Karabay [Turquie] ; Mehmet Yahyao Lu [Turquie] | Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment |
| 000A76 (2012) |
Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. Rudenko | Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). |
| 000B71 (2011-07-01) |
Odile Launay [France] ; Corinne Desaint [France] ; Christine Durier [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Christine Jacomet [France] ; Gilles Pialoux ; Jade Ghosn [France] ; François Raffi [France] ; David Rey ; Faiza Ajana ; Nathalie Colin De Verdière [France] ; Jacques Reynes [France] ; Valérie Foubert [France] ; François Roman ; Jeanne-Marie Devaster ; Jean-François Delfraissy [France] ; Jean-Pierre Aboulker [France] ; Christian Michelet [France] | Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. |
| 000D93 (2010) |
N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov | [Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)]. |
| 000F74 (2010) |
Ewa Wi Sik-Szewczyk [Pologne] ; Magdalena Romanowska [Pologne] ; Paweł Mielnik [Pologne] ; Hanna Chwali Ska-Sadowska [Pologne] ; Lidia B. Brydak [Pologne] ; Marzena Olesi Ska [Pologne] ; Jakub Z Bek [Pologne] | Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety |
| 001044 (2009) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Safety, Immunogencity and Efficacy of a Cold-Adapted A/Ann Arbor/6/60 (H2N2) Vaccine in Mice and Ferrets |
| 001225 (2008) |
Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky | Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). |
| 001361 (2007) |
Robert B. Couch [États-Unis] ; Patricia Winokur [États-Unis] ; Rebecca Brady [États-Unis] ; Robert Belshe [États-Unis] ; Wilbur H. Chen [États-Unis] ; Thomas R. Cate [États-Unis] ; Bryndis Sigurdardottir [États-Unis] ; Amy Hoeper [États-Unis] ; Irene L. Graham [États-Unis] ; Robert Edelman [États-Unis] ; Fenhua He [États-Unis] ; Diane Nino [États-Unis] ; Jose Capellan [États-Unis] ; Frederick L. Ruben [États-Unis] | Safety and Immunogenicity of a High Dosage Trivalent Influenza Vaccine among Elderly Subjects |
| 001687 (2004) |
I. A. Leneva [Russie] ; R. G. Glushkov [Russie] ; T. A. Gus Ova [Russie] | Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review) |
| 002B90 (1975) |
Peter F. Wright [États-Unis] ; Sarah H. Sell [États-Unis] ; Tatsuhiko Shinozaki [États-Unis] ; Juliette Thompson [États-Unis] ; David T. Karzon [États-Unis] | Safety and antigenicity of influenza A/Hong Kong/68-ts-1 [E] (H3N2) vaccine in young seronegative children |
| 002D78 (????) |
Iu A. Desheva ; G V Danini ; E P Grigor'Eva ; S A Donina ; I V Kiseleva ; A R Rekstin ; L A Ermakova ; V K Natsina ; V M Nikolaeva ; N I Lonskaia ; G A El'Shina ; V G Zhavoronkov ; V P Drinevski ; M K Erofeeva ; A N Na Khin ; L G Rudenko | [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. |
| 002D84 (????) |
E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko | [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. |
| 002D90 (????) |
F I Polezhaev ; G N Budilovski ; L M Garmashova ; Iu R. Rome Ko-Gurko ; A Iu Egorov | [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)]. |
